Quebec’s cancer research funding agency Oncopole has started a series of blog posts with its first featuring the Opal patient engagement platform, which is designed, developed and operated by the Kildea lab at the RI-MUHC.
The post is entitled “Transformer la recherche en réalité prometteuse – Le portail patient Opal : vers des soins de santé plus accessibles”.
Thank you to Oncopole for recognizing our work!
Link to Oncopole’s blog post
